Live Breaking News & Updates on Clinical cancer research

Stay informed with the latest breaking news from Clinical cancer research on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Clinical cancer research and stay connected to the pulse of your community

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through AmpligenOCALA, Fla., March 25, 2024 -- AIM ImmunoTech Inc. today announced the...

United-states , American , Thomask-equels , Facebook , Exchange-commission , Immunotech-inc , Erasmus-university-medical-center , Early-access-program , Linkedin , Astrazeneca , Clinical-cancer-research

First-Line Anlotinib Appears Effective in Soft Tissue Sarcoma

First-line treatment with anlotinib may benefit patients with soft tissue sarcoma who are not eligible for cytotoxic chemotherapy, according to researchers. First-line treatment with anlotinib may benefit patients with soft tissue sarcoma who are not eligible for cytotoxic chemotherapy.

Clinical-cancer-research , Clinical-cancer ,

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Lebanon , Ali-bazarbachi , European-society-for-blood , Clinical-cancer-research , American-university-of-beirut , American-university , European-society , Marrow-transplantation , Posttransplant-outcomes-over-two-decades , Older-patients , Acute-myeloid-leukemia , Clinical-cancer

Rising survival rates for AML patients over 65 after allogeneic hematopoietic stem cell transplant

Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid leukemia (AML) between 2000 and 2021, leukemia-free and overall survival improved significantly over time.

United-states , Lebanon , American , Ali-bazarbachi , Clinical-cancer-research , American-university-of-beirut , American-association-for-cancer-research , European-society-for-blood , American-association , Cancer-research , American-university , European-society

PATIENTS IN SCOTLAND WITH AN ADVANCED FORM OF PROSTATE CANCER CAN NOW ACCESS LYNPARZA (OLAPARIB) WITH ABIRATERONE AND PREDNISONE OR PREDNISOLONE WITHOUT A BIOMARKER TEST

PATIENTS IN SCOTLAND WITH AN ADVANCED FORM OF PROSTATE CANCER CAN NOW ACCESS LYNPARZA (OLAPARIB) WITH ABIRATERONE AND PREDNISONE OR PREDNISOLONE WITHOUT A BIOMARKER TEST

London , City-of , United-kingdom , United-states , Cambridge , Cambridgeshire , Canada , Scotland , British , Robert-jones , David-long , Tom-keith-roach

Corrections Issued for Papers by Dana-Farber Researchers

Several corrections have been made to study reports written by researchers at the Dana-Farber Cancer Institute since errors in these and other papers were the topic of controversy last month. Several corrections have been made to study reports written by researchers at the Dana-Farber Cancer Institute.

Barrett-rollins , Sholto-david , Dana-farber-cancer-institute , Clinical-cancer-research , For-better-sciencewritten , Nature-medicine , Nature-immunology , Clinical-oncology ,

Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , American , James-levine , Kiki-patel , Mark-erlander , Richa-kumari , Nasdaq , Taft-communications , Exchange-commission , Gilmartin-group , Clinical-cancer-research , Pfizer

The promising results of a phase II clinical study for Akeso's Cadonilimab (PD-1/CTLA-4) combined standard treatment for first-line treatment of R/M cervical cancer has been published in Clinical Canc

The promising results of a phase II clinical study for Akeso's Cadonilimab (PD-1/CTLA-4) combined standard treatment for first-line treatment of R/M cervical cancer has been published in Clinical Canc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong-kong , China , United-states , American , Prnewswire-akeso , China-national-medical-products-administration , American-society-of-clinical-oncology , Clinical-cancer-research , American-association-for-cancer-research , Akeso-inc , Contact-akeso-business-development , American-association

Best Time To Take Vitamin C: Morning Or Night In 2024?

Are you wondering when is the best time to take vitamin C daily? Let’s see what science says on how to time your doses in 2024.

Elif-piskin , Bita-hashtroody , Nahid-ramezani-jolfaie , Vuk-uskokovi , Khalid-hajissa , Vuyolwethu-mxinwa , Albertus-kotze-basson , Mohammad-reza-mohammadi , Jacopo-sabbatinelli , Esra-capanoglu , Khanyisani-ziqubu , Noor-fatmawati-mokhtar

Early imaging can reveal if melanoma immunotherapy will work

"...imaging tumors early can improve how clinicians develop personalized treatment plans for each patient."

Michael-farwell , University-of-pennsylvania , Clinical-cancer-research , Merck-sharp-dohme , Perelman-school-of-medicine , Perelman-school , Merck-sharp ,

Live Breaking News & Updates on Clinical cancer research

"...imaging tumors early can improve how clinicians develop personalized treatment plans for each patient."Michael-farwell , University-of-pennsylvania , Clinical-cancer-research , Merck-sharp-dohme , Perelman-school-of-medicine , Perelman-school , Merck-sharp ,

"...imaging tumors early can improve how clinicians develop personalized treatment plans for each patient."

Michael-farwell , University-of-pennsylvania , Clinical-cancer-research , Merck-sharp-dohme , Perelman-school-of-medicine , Perelman-school , Merck-sharp ,